CN1833721A - 一种胸腺五肽与干扰素的组合物 - Google Patents
一种胸腺五肽与干扰素的组合物 Download PDFInfo
- Publication number
- CN1833721A CN1833721A CN 200610076271 CN200610076271A CN1833721A CN 1833721 A CN1833721 A CN 1833721A CN 200610076271 CN200610076271 CN 200610076271 CN 200610076271 A CN200610076271 A CN 200610076271A CN 1833721 A CN1833721 A CN 1833721A
- Authority
- CN
- China
- Prior art keywords
- interferon
- thymopentin
- compositions
- alpha
- injection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100762710A CN100435843C (zh) | 2006-04-21 | 2006-04-21 | 一种胸腺五肽与干扰素的组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100762710A CN100435843C (zh) | 2006-04-21 | 2006-04-21 | 一种胸腺五肽与干扰素的组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1833721A true CN1833721A (zh) | 2006-09-20 |
CN100435843C CN100435843C (zh) | 2008-11-26 |
Family
ID=37001711
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100762710A Active CN100435843C (zh) | 2006-04-21 | 2006-04-21 | 一种胸腺五肽与干扰素的组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100435843C (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102078598A (zh) * | 2011-01-06 | 2011-06-01 | 河南亚卫动物药业有限公司 | 一种防治猪病毒性疾病的注射剂及其制备方法 |
CN108721603A (zh) * | 2017-04-14 | 2018-11-02 | 中国医学科学院基础医学研究所 | 干扰素α-1a在制备用于治疗癌症的药物中的用途 |
CN111671886A (zh) * | 2020-03-05 | 2020-09-18 | 上海甘翼生物医药科技有限公司 | 一种预防高危易感人群感染冠状病毒或发生冠状病毒感染疾病的药物组合及其用途 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2542662A1 (en) * | 2003-10-17 | 2005-04-28 | Novo Nordisk A/S | Pharmaceutical combinations comprising il-21 |
CN1676162A (zh) * | 2004-03-30 | 2005-10-05 | 北京中科亚光生物科技有限公司 | 一种胸腺五肽注射液 |
DE602004022523D1 (de) * | 2004-07-02 | 2009-09-24 | Novagali Pharma Sa | Verwendung von Emulsionen zur intra- und periocularen Injection |
-
2006
- 2006-04-21 CN CNB2006100762710A patent/CN100435843C/zh active Active
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102078598A (zh) * | 2011-01-06 | 2011-06-01 | 河南亚卫动物药业有限公司 | 一种防治猪病毒性疾病的注射剂及其制备方法 |
CN102078598B (zh) * | 2011-01-06 | 2012-11-28 | 河南亚卫动物药业有限公司 | 一种防治猪病毒性疾病的注射剂及其制备方法 |
CN108721603A (zh) * | 2017-04-14 | 2018-11-02 | 中国医学科学院基础医学研究所 | 干扰素α-1a在制备用于治疗癌症的药物中的用途 |
CN108721603B (zh) * | 2017-04-14 | 2020-11-13 | 中国医学科学院基础医学研究所 | 干扰素α-1a在制备用于治疗癌症的药物中的用途 |
CN111671886A (zh) * | 2020-03-05 | 2020-09-18 | 上海甘翼生物医药科技有限公司 | 一种预防高危易感人群感染冠状病毒或发生冠状病毒感染疾病的药物组合及其用途 |
CN111671886B (zh) * | 2020-03-05 | 2022-11-15 | 上海甘翼生物医药科技有限公司 | 一种预防高危易感人群感染冠状病毒或发生冠状病毒感染疾病的药物组合及其用途 |
Also Published As
Publication number | Publication date |
---|---|
CN100435843C (zh) | 2008-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1031940A (zh) | 通过粘膜给药的配方及其制备方法 | |
CN1059659A (zh) | 病毒性肝炎的诊断和治疗 | |
CN100435843C (zh) | 一种胸腺五肽与干扰素的组合物 | |
CN1269498C (zh) | 一种具有解热作用的中药组合物的质量控制方法 | |
CN1679924A (zh) | 复方胰岛素能量合剂制剂及其应用 | |
CN1876045A (zh) | 一种中药组合物制剂及其制备方法和质量控制方法 | |
CN1165343C (zh) | 减毒的非免疫原性痘病毒和副痘病毒衍生的多功能副痘病毒免疫诱导剂用作药物的新适应症 | |
KR100394382B1 (ko) | 천연사람α-인터페론으로구성된약학조성물 | |
CN1739794A (zh) | 一种胸腺素α1的水溶液制剂、其制备方法及应用 | |
US20080075691A1 (en) | Permucosal Composition and Method of Improving Permucosal Absorption | |
CN1193790C (zh) | 胸腺肽组合物注射剂及其制备方法 | |
CN1730014A (zh) | 苦木注射剂新的给药途径及其制备工艺、新的适应症 | |
US20100144855A1 (en) | APPLICATION OF SEDOISOPROSAN FOR PREPARATION OF MEDICINE FOR TREATMENT OF HUMAN HBeAg POSITIVE CHRONIC HEPATITIS B | |
CN1225249C (zh) | 一种提高免疫力的抗病毒药及制备方法 | |
CN1108815C (zh) | 复方α干扰素含片及其制备方法 | |
US11883418B2 (en) | Compound TSYI-ZAC for inhibiting dengue virus infection and medicinal use thereof | |
CN112138147B (zh) | 一种胸腺法新或胸腺五肽的口服药物组合物 | |
CN103054805A (zh) | 一种无针注射用注射剂的制备方法及应用 | |
CN1404875A (zh) | 一种乙型肝炎疫苗 | |
CN100335038C (zh) | 含有生物活性物质和中药成分包封的无机盐纳米粒子的制备方法 | |
CN1768762A (zh) | 鹿茸精注射剂新的给药途径及其制备工艺、新适应症 | |
CN1889976A (zh) | 抗疱疹药物组合物、生产基于其的剂型的方法及其使用方法 | |
CN101019872A (zh) | 抗病毒纳米脂质体药物及其制备方法 | |
CN1757398A (zh) | 含有和包封中药成分的无机盐纳米粒子的制备方法及其应用 | |
WO2022079205A1 (en) | Use of ifn-alpha polypeptides for the treatment of coronavirus infections |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: No. 8, Gucheng West Road, Beijing, Shijingshan District: 100043 Co-patentee after: Jilin Yixin pharmaceutical Limited by Share Ltd. Patentee after: Beijing Guodan Medicine Technology Development Co.,Ltd. Address before: No. 8, Gucheng West Road, Beijing, Shijingshan District: 100043 Co-patentee before: Jilin A-Think Pharmaceutical Co.,Ltd. Patentee before: Beijing Guodan Medicine Technology Development Co.,Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20090320 Address after: No. 1, one heart road, Shuangyang Economic Development Zone, Changchun: 130616 Patentee after: Jilin Yixin pharmaceutical Limited by Share Ltd. Address before: No. 8, Gucheng West Road, Beijing, Shijingshan District: 100043 Co-patentee before: Jilin Yixin pharmaceutical Limited by Share Ltd. Patentee before: Beijing Guodan Medicine Technology Development Co.,Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: JILIN YIXIN PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: BEIJING GUO DAN DRUG TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20090320 |
|
C56 | Change in the name or address of the patentee |
Owner name: JILIN A-THINK PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: JILIN YIXIN PHARMACEUTICAL CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 130616, No. 1, one heart road, Shuangyang Economic Development Zone, Changchun Patentee after: SINOPHARM A-THINK PHARMACEUTICAL Co.,Ltd. Address before: 130616, No. 1, one heart road, Shuangyang Economic Development Zone, Changchun Patentee before: Jilin Yixin pharmaceutical Limited by Share Ltd. |